Intuitive Surgical, Inc. (NASDAQ: ISRG) experienced a modest share price dip to USD 439.22, down 1.9 points, as trading volume exceeded its average. The company holds a significant market capitalization and remains a key player in the healthcare instruments sector.
Company Overview
Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California. The company develops, manufactures, and markets medical devices aimed at advancing minimally invasive care. Its flagship product, the da Vinci Surgical System, facilitates complex surgical procedures through a less invasive approach. The firm also offers the Ion endoluminal system for diagnostic procedures such as minimally invasive lung biopsies.
The product portfolio extends across stapling, energy, and core instrumentation, along with training solutions, services, and integrated digital capabilities. These offerings support healthcare providers with operational insights and workflow efficiencies.
The company operates internationally, aligning with hospitals and clinics to expand patient access to advanced surgical technologies.
Current Stock Performance
On the latest trading day, ISRG closed at USD 439.22. This represents a decline of 1.9 points, or approximately 0.43%, compared to the previous close. The trading volume reached 2,970,464 shares, higher than its average volume of 2,161,625 shares, signaling increased market activity. The 52-week price range stands between USD 425 and USD 616.
For investors, the price movement illustrates short-term volatility, which can occur even within the context of strong market fundamentals. The absence of dividends indicates reinvestment preference over direct shareholder payout, common in growth-focused technology-oriented healthcare firms.
Market Position and Sector
Intuitive Surgical belongs to the Medical – Instruments & Supplies industry within the broader healthcare sector. This sector has experienced consistent demand due to global trends in medical technology adoption and the shift toward minimally invasive procedures.
With a current market capitalization of approximately USD 157.45 billion, the company is among the largest in its field. This valuation reflects investor confidence and the firm’s dominant position in robotic-assisted surgical technologies.
Governance and Leadership
Gary S. Guthart serves as Chief Executive Officer. Leadership stability and focused strategic vision have contributed to the company’s sustained product innovation and market expansion. Under Guthart’s tenure, Intuitive Surgical has maintained its reputation for reliability, regulatory compliance, and customer service.
Key Financial Data
- Share Price: USD 439.22
- Market Capitalization: USD 157,450,050,965
- Last Dividend: USD 0.00
- 52-Week Range: USD 425 to USD 616
- Daily Change: -1.9 points (-0.43%)
- Trading Volume: 2,970,464 shares
- Average Volume: 2,161,625 shares
For long-term stakeholders, these figures represent both the scale of operations and the company’s growth orientation. The absence of dividend payments is characteristic of firms prioritizing reinvestment into R&D and market expansion.
Trading Details
- Exchange: NASDAQ Global Select
- Ticker Symbol: ISRG
- ISIN: US46120E6023
- CUSIP: 46120E602
- CIK: 0001035267
- IPO Date: June 16, 2000
These identifiers are used in regulatory filings, market tracking, and institutional trading systems. Investors can reference these details for accurate due diligence and compliance reporting.
FAQ
- Does Intuitive Surgical pay dividends? No, the last dividend was USD 0.00.
- Where is the company headquartered? Sunnyvale, California, United States.
- How many employees does it have? 15,638 full-time employees.
- On which exchange is ISRG traded? NASDAQ Global Select Market.
- What industry does the company operate in? Medical – Instruments & Supplies.
Conclusion
Intuitive Surgical remains a key player in the medical instruments industry, backed by a substantial market cap and innovative product range. Recent stock movement shows short-term fluctuations within a healthy longer-term outlook. Investors should monitor both sector trends and company developments when making portfolio decisions.
Disclaimer
This article is for informational purposes only. It does not constitute financial advice. Investors should perform their own research before making investment decisions.
Official Announcement
For full information about the company, see the link below.